146 related articles for article (PubMed ID: 23500390)
1. The late Na current as a therapeutic target: where are we?
Maier LS; Sossalla S
J Mol Cell Cardiol; 2013 Aug; 61():44-50. PubMed ID: 23500390
[TBL] [Abstract][Full Text] [Related]
2. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
[TBL] [Abstract][Full Text] [Related]
3. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction.
Song Y; Shryock JC; Wagner S; Maier LS; Belardinelli L
J Pharmacol Exp Ther; 2006 Jul; 318(1):214-22. PubMed ID: 16565163
[TBL] [Abstract][Full Text] [Related]
4. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
5. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
6. Sophocarpine attenuates the Na(+)-dependent Ca2(+) overload induced by Anemonia sulcata toxin-increased late sodium current in rabbit ventricular myocytes.
Zhang S; Ma JH; Zhang PH; Luo AT; Ren ZQ; Kong LH
J Cardiovasc Pharmacol; 2012 Oct; 60(4):357-66. PubMed ID: 23064241
[TBL] [Abstract][Full Text] [Related]
7. A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Maier LS
J Cardiovasc Pharmacol; 2009 Oct; 54(4):279-86. PubMed ID: 19333133
[TBL] [Abstract][Full Text] [Related]
8. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
9. Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
Sossalla S; Maier LS
Pharmacol Ther; 2012 Mar; 133(3):311-23. PubMed ID: 22133843
[TBL] [Abstract][Full Text] [Related]
10. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
[TBL] [Abstract][Full Text] [Related]
11. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain.
Hoyer K; Song Y; Wang D; Phan D; Balschi J; Ingwall JS; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2011 May; 337(2):513-23. PubMed ID: 21325441
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
13. Ranolazine: an antianginal drug with antiarrhythmic properties.
Tamargo J; Caballero R; Delpón E
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):815-27. PubMed ID: 21809962
[TBL] [Abstract][Full Text] [Related]
14. Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease.
Toischer K; Hartmann N; Wagner S; Fischer TH; Herting J; Danner BC; Sag CM; Hund TJ; Mohler PJ; Belardinelli L; Hasenfuss G; Maier LS; Sossalla S
J Mol Cell Cardiol; 2013 Aug; 61():111-22. PubMed ID: 23570977
[TBL] [Abstract][Full Text] [Related]
15. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.
Sossalla S; Kallmeyer B; Wagner S; Mazur M; Maurer U; Toischer K; Schmitto JD; Seipelt R; Schöndube FA; Hasenfuss G; Belardinelli L; Maier LS
J Am Coll Cardiol; 2010 May; 55(21):2330-42. PubMed ID: 20488304
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.
Belardinelli L; Shryock JC; Fraser H
Heart; 2006 Jul; 92 Suppl 4(Suppl 4):iv6-iv14. PubMed ID: 16775092
[TBL] [Abstract][Full Text] [Related]
17. New treatment options for late Na current, arrhythmias, and diastolic dysfunction.
Maier LS
Curr Heart Fail Rep; 2012 Sep; 9(3):183-91. PubMed ID: 22767404
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.
Fraser H; Belardinelli L; Wang L; Light PE; McVeigh JJ; Clanachan AS
J Mol Cell Cardiol; 2006 Dec; 41(6):1031-8. PubMed ID: 17027025
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Late Sodium Current as an Innovative Antiarrhythmic Strategy.
Bengel P; Ahmad S; Sossalla S
Curr Heart Fail Rep; 2017 Jun; 14(3):179-186. PubMed ID: 28455610
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium.
Shryock JC; Belardinelli L
Br J Pharmacol; 2008 Mar; 153(6):1128-32. PubMed ID: 18071302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
